These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 7781437

  • 21. Interferon treatment for hepatitis C virus infection in patients on haemodialysis.
    Chan TM, Wu PC, Lau JY, Lok AS, Lai CL, Cheng IK.
    Nephrol Dial Transplant; 1997 Jul; 12(7):1414-9. PubMed ID: 9249778
    [Abstract] [Full Text] [Related]

  • 22. Effect of alcohol intake on the efficacy of interferon therapy in patients with chronic hepatitis C as evaluated by multivariate logistic regression analysis.
    Mochida S, Ohnishi K, Matsuo S, Kakihara K, Fujiwara K.
    Alcohol Clin Exp Res; 1996 Dec; 20(9 Suppl):371A-377A. PubMed ID: 8986241
    [Abstract] [Full Text] [Related]

  • 23. Comparative efficacy of a high or low dose of interferon alpha 2b in chronic hepatitis C: a randomized controlled trial.
    Tassopoulos NC, Karvountzis G, Touloumi G, Delladetsima JK, Papatheodoridis GV, Katsoulidou A, Retalis G, Hatzakis A.
    Am J Gastroenterol; 1996 Sep; 91(9):1734-8. PubMed ID: 8792690
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Recombinant human interferon alpha-2a therapy for chronic hepatitis C with or without cirrhosis: comparison of 3 or 6 MU for 1 year.
    Caporaso N, Suozzo R, Morisco F, D'Antonio M, Romano M, Coltorti M.
    Ital J Gastroenterol; 1993 Sep; 25(9):482-6. PubMed ID: 8123895
    [Abstract] [Full Text] [Related]

  • 27. alpha-Interferon treatment of chronic hepatitis C: a controlled, multicentre, prospective study.
    Angelini G, Sgarbi D, Colombari R, Bezzi A, Castagnini A, de Berardinis F, Conti A, di Piramo D, Dolci L, Falezza G.
    Digestion; 1995 Sep; 56(3):199-203. PubMed ID: 7657044
    [Abstract] [Full Text] [Related]

  • 28. Can the response to interferon treatment be predicted in patients with chronic active hepatitis C?
    Lin R, Schoeman MN, Craig PI, Bilous M, Grierson J, McDonald JA, Batey RG, Farrell GC.
    Aust N Z J Med; 1991 Jun; 21(3):387-92. PubMed ID: 1953524
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Efficacy of interferon combined glycyrrhizin therapy in patients with chronic hepatitis C resistant to interferon therapy].
    Okuno T, Arai K, Shindo M.
    Nihon Rinsho; 1994 Jul; 52(7):1823-7. PubMed ID: 8078202
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Therapy of active chronic hepatitis with recombinant alpha 2b-interferon: an 18 month follow-up.
    Bresci G, Parisi G, Banti S, Bertoni M.
    Eur J Med; 1993 Jul; 2(6):349-52. PubMed ID: 8252180
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Results of long term interferon treatment in non A non B/C chronic active hepatitis. The French Group for the study of NANB/C chronic hepatitis treatment.
    Métreau JM.
    Gut; 1993 Jul; 34(2 Suppl):S112-3. PubMed ID: 8314474
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Long-term follow-up of chronic hepatitis C after treatment with recombinant interferon alpha-2a].
    Hopf U, Küther S, König V, Heuft H, Berg T, Bauditz J, Soltani K, Lobeck H, Huhn D.
    Z Gastroenterol; 1994 Aug; 32(8):425-30. PubMed ID: 7975783
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.